On Wednesday, Shares of EMC Corporation (NYSE:EMC), gained 1.81% to $25.38, hitting its lowest level.
EMC Corporation, declared that its second-quarter 2015 financial results and news release are accessible on the EMC Newsroom (http://www.emc.com/q2-2015-earnings) and the U.S. Securities and Exchange Commission website (http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000790070&owner=exclude&count=40).
EMC will talk about its second-quarter 2015 financial results and business outlook during a conference call and live webcast recently at 8:30 a.m. ET.
EMC Corporation develops, delivers, and supports information infrastructure and virtual infrastructure technologies, solutions, and services. It offers enterprise storage systems and software deployed in storage area networks (SAN), networked attached storage (NAS), unified storage combining NAS and SAN, object storage, and/or direct attached storage environments, in addition to provides a portfolio of backup products that support a range of enterprise application workloads.
Shares of Abbott Laboratories (NYSE:ABT), inclined 2.45% to $50.98, during its last trading session, hitting its highest level.
Abbott Laboratories declared financial results for the second quarter ended June 30, 2015.
- Second-quarter worldwide sales of $5.2 billion raised 10.8 percent on an operational basis and 2.2 percent on a stated basis. Worldwide sales raised 6.4 percent not taking into account the impact of 2014 acquisitions and foreign exchange.
- Diluted EPS from ongoing operations on both an adjusted and GAAP basis was $0.52 in the second quarter.
- Abbott’s full-year 2015 adjusted EPS guidance range for ongoing operations remains unchanged at $2.10 to $2.20. Projected full-year 2015 EPS for ongoing operations under GAAP is $1.50 to $1.60.
- Second-quarter gross margin ratio was ahead of expectations, primarily driven by continued improvements in Diagnostics and Nutrition.
- In the second quarter, Abbott received European approval for Absorb GT1TM, which combines the world’s first fully dissolving stent with a next-generation delivery catheter; accomplished submissions for regulatory approval of Absorb in Japan and the U.S.; presented for U.S. regulatory approval of its FreeStyle® Libre Pro Flash Glucose Monitoring System for professional use; and received U.S. FDA clearance for a first-of-its-kind blood test for its i-STAT® handheld system to aid in detecting early pregnancy in emergency situations.
Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; intrahepatic cholestasis or depressive symptoms; gynecological disorders; dyslipidemia; hypertension; hypothyroidism; pain, fever, and inflammation; hormone replacement therapy; anti-infective and influenza vaccines; and product that regulates physiological rhythm of the colon.
Finally, The Hartford Financial Services Group, Inc. (NYSE:HIG), ended its last trade with -0.66% loss, and closed at $46.41.
The Hartford Financial Services Group, in partnership with NBC 5 Chicago, has launched the Small Business Boost contest to reward Chicago-area small business owners who play a big role in their local communities. The Small Business Boost is part of The Hartford’s Communities with HART program, which supports local communities by assisting small businesses grow and by inspiring new generations of entrepreneurs.
“We are excited to invite members of the Chicago-area communities to recognize their favorite small business for all that they do to support their local neighborhoods,” said Diane Cantello, vice president of corporate responsibility at The Hartford. “The Hartford is passionate about assisting small businesses succeed and we deeply appreciate the role they play in contributing to the vibrancy of local communities.”
The Hartford Financial Services Group, Inc., through its auxiliaries, provides insurance and financial services to individual and business customers primarily in the United States. The company’s Commercial Lines segment offers workers compensation, property, automobile, marine, umbrella, liability, and livestock coverages, in addition to customized insurance products and risk administration services, counting professional liability, bond, and specialty casualty coverages.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.